Finance

Lists
SPARC:NSE
Sun Pharma Advanced Research Co Ltd
193,78 ₹
-1,21%
(-2,38) 1D
6 қар., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SPARC...
Open
195,00 ₹
High
196,72 ₹
Low
189,85 ₹
Mkt. cap
62,78 млрд
Avg. vol.
962,34 м.
Volume
873,51 м.
P/E ratio
3,96
52-wk high
289,00 ₹
52-wk low
108,00 ₹
EPS
48,91 ₹
Shares outstanding
255,99 млн
No. of employees
279
Open
195,00 ₹
High
196,72 ₹
Low
189,85 ₹
Mkt. cap
62,78 млрд
Avg. vol.
962,34 м.
Volume
873,51 м.
P/E ratio
3,96
52-wk high
289,00 ₹
52-wk low
108,00 ₹
EPS
48,91 ₹
Shares outstanding
255,99 млн
No. of employees
279
News stories
From web sources and news partners
About Sun Pharma Advanced Research Co Ltd
CEO-
Employees279
Founded2006
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitesparc.life
Last report
2026 ж. 02 қар.
Fiscal period
Q2 2027
- / -
Revenue / Est. (INR)
536,50 млн / -
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
2026 ж. қыр.
Revenue
84,50 млн
18,53 млрд
399,20 млн
536,50 млн
Cost of goods sold
72,10 млн
115,06 млн
76,60 млн
99,50 млн
Cost of revenue
72,10 млн
115,06 млн
76,60 млн
99,50 млн
Research and development expenses
62,70 млн
28,44 млн
132,60 млн
92,50 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
424,60 млн
557,37 млн
448,00 млн
448,50 млн
Operating expense
604,50 млн
605,33 млн
684,60 млн
678,90 млн
Total operating expenses
676,60 млн
720,39 млн
761,20 млн
778,40 млн
Operating income
-592,10 млн
17,81 млрд
-362,00 млн
-241,90 млн
Other non operating income
-
-116,03 млн
236,60 млн
-
EBT including unusual items
-803,50 млн
17,61 млрд
-206,70 млн
-243,10 млн
EBT excluding unusual items
-679,90 млн
17,61 млрд
-206,70 млн
-243,10 млн
Income tax expense
700,00 м.
-3,84 млн
1,10 млн
800,00 м.
Effective tax rate
-0,09%
-0,02%
-0,53%
-0,33%
Other operating expenses
91,50 млн
-3,44 млн
82,00 млн
115,90 млн
Net income
-804,20 млн
17,61 млрд
-207,80 млн
-243,90 млн
Net profit margin
-951,72%
95,04%
-52,05%
-45,46%
Earnings per share
-
-
-
-
Interest and investment income
-
102,87 млн
-
-
Interest expense
-87,80 млн
-90,07 млн
-81,30 млн
-1,20 млн
Net interest expenses
-87,80 млн
12,80 млн
-81,30 млн
-1,20 млн
Depreciation and amortization charges
25,70 млн
22,96 млн
22,00 млн
22,00 млн
EBITDA
-570,75 млн
17,83 млрд
-342,34 млн
-219,90 млн
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google қолданбалары